Research
Research
September 10, 2024 • 3 Min
A New Combination Targeting the RAS Pathway
Researchers are testing two new drugs that target the RAS pathway, to make standard chemotherapy more effective.
An affiliate of the Lustgarten Foundation, the largest private funder of pancreatic cancer research.
Research
August 14, 2024 • 5 Min
Early Study Shows Exercise Alone Can Reduce Inflammation
Dr. Zobeida Cruz-Monserrate is studying how exercise can reduce inflammation, and how that impacts pancreatic cancer.
Research
August 9, 2024 • 4 Min
Chemo Before Surgery Doubles Overall Survival in Some Patients
Dr. Marco Del Chiaro explains the results of an international study of outcomes for patients who had neoadjuvant treatment before surgery.